よむ、つかう、まなぶ。
参考資料3 有効性評価に基づく大腸がん検診ガイドライン2024年度版 (63 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_71872.html |
| 出典情報 | がん検診のあり方に関する検討会（第46回 3／23）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
34.
35.
36.
37.
99.
S9.
40.
41.
Vermeer NOCA, yan der Valk MJM, Snijders HS, Vasen HEFA, Gerritsen van der
Hoop A, Guicherit OR, Liefers GJ, van de Velde CJH, Stiggelbout AM, Peeters
KCMJ. Psychological distress and qualty of jfe following positive fecal occult
blood testing in colorectal cancer screening. Psychooncology. 2020:29(6):1084-91.
doi: 10.1002/pon.5381. PMID 32237002
Gordon NP Green BB. Factors associated with use and non-use of the Fecal
Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Respomse to a
2012 outreach screening program: a survey study BMC Public Health.
2015:15:546. doi: 10.1186/s12889-015-1908-x. PMID: 26062732
Chambers JA. CalJander AS, Grangeret R, O'Carroll RE. Attitudes towards the
Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FTTD)
for colorectal cancer screening: percenved ease of completion and sgust. BMC
Cancer. 2016:16:96. doi: 10.1186/s12885-016-2133-4. PMID: 26872450
Atkin WS, Hart A, Edwards R, Mclntyre P Aubrey R, Wardle J, Sutton 8, Cuzick
J Northover JM. Uptake, yield of neoplasia, and adverse effects of flexible
sigmoidoscopy screening. Gut. 1998:42(4):560-5. doi: 10.1136/gut,.42.4.560. PMID:
9616321
Atkm WS. Cook CE Cuzick J, Bdwards R, Northover JM, Wardle Ji UK Flexible
Sigmoidoscopy Screening Trial Investigators. Single flexble sigmoidoscopy
screening to prevent colorectal cancer: baseline findings of a UK multicentre
randomised trial. Lancet. 2002:359(9814):1291-300. doi: 10.1016/S0140-
6736(02)08268-5. PMID: 11965274
Atkin WS, Edwards R, Kralj-Hans 1, Wooldrage KK, Hart AR, Northoyer JM,
Parkin DM, Wardle J, Duffy SW, Cugck Ji UK Flexible Sigmoidoscopy Trial
nvestigators. Once-only flexible sigmoidoscopy screen1ng in prevention of
colorectal cancer: a multicentre randomised controlled trial. Lancet.
2010:375(9726):1624-33. doi: 10.1016/80140-6786(10)60551-X. PMID: 20430429
Segnan N, Senore C, Andreoni B, Aste H, Bonelji 工, Crosta C, Ferrars ド,
Gasperoni1 S, Penna A, Risio M, Rossini FP Sciallero S, Zappa M, Atkin WS
SCORE Working Group - Italy. Basehne Findings of the Itahan IMulticenter
Randomized Controlled Trial of "Once-Only SigmoidoscopyーーSCORE.J Natl
Cancer Inst. 2002:94(23):1763-72. doi: 10.1093/jnc794.23.1763. PMID 12464648
Segnan N, Armaroli P Bonelhi 1L, Risio M, Sciallero S, Zappa M, Andreoni B,
Arrigomi A, Bisanti L, Casella C, Crosta C, Faleini F, Ferrero E, Gnacomn 為,
Giuliami O, Santarelh A, Visioli CB, Zanetti R, Atkin WS, Senore Ci SCORE
Working Group. Once-Only Sigmoidoscopy in Colorecta1 Cancer Screen1mg:
63
35.
36.
37.
99.
S9.
40.
41.
Vermeer NOCA, yan der Valk MJM, Snijders HS, Vasen HEFA, Gerritsen van der
Hoop A, Guicherit OR, Liefers GJ, van de Velde CJH, Stiggelbout AM, Peeters
KCMJ. Psychological distress and qualty of jfe following positive fecal occult
blood testing in colorectal cancer screening. Psychooncology. 2020:29(6):1084-91.
doi: 10.1002/pon.5381. PMID 32237002
Gordon NP Green BB. Factors associated with use and non-use of the Fecal
Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Respomse to a
2012 outreach screening program: a survey study BMC Public Health.
2015:15:546. doi: 10.1186/s12889-015-1908-x. PMID: 26062732
Chambers JA. CalJander AS, Grangeret R, O'Carroll RE. Attitudes towards the
Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FTTD)
for colorectal cancer screening: percenved ease of completion and sgust. BMC
Cancer. 2016:16:96. doi: 10.1186/s12885-016-2133-4. PMID: 26872450
Atkin WS, Hart A, Edwards R, Mclntyre P Aubrey R, Wardle J, Sutton 8, Cuzick
J Northover JM. Uptake, yield of neoplasia, and adverse effects of flexible
sigmoidoscopy screening. Gut. 1998:42(4):560-5. doi: 10.1136/gut,.42.4.560. PMID:
9616321
Atkm WS. Cook CE Cuzick J, Bdwards R, Northover JM, Wardle Ji UK Flexible
Sigmoidoscopy Screening Trial Investigators. Single flexble sigmoidoscopy
screening to prevent colorectal cancer: baseline findings of a UK multicentre
randomised trial. Lancet. 2002:359(9814):1291-300. doi: 10.1016/S0140-
6736(02)08268-5. PMID: 11965274
Atkin WS, Edwards R, Kralj-Hans 1, Wooldrage KK, Hart AR, Northoyer JM,
Parkin DM, Wardle J, Duffy SW, Cugck Ji UK Flexible Sigmoidoscopy Trial
nvestigators. Once-only flexible sigmoidoscopy screen1ng in prevention of
colorectal cancer: a multicentre randomised controlled trial. Lancet.
2010:375(9726):1624-33. doi: 10.1016/80140-6786(10)60551-X. PMID: 20430429
Segnan N, Senore C, Andreoni B, Aste H, Bonelji 工, Crosta C, Ferrars ド,
Gasperoni1 S, Penna A, Risio M, Rossini FP Sciallero S, Zappa M, Atkin WS
SCORE Working Group - Italy. Basehne Findings of the Itahan IMulticenter
Randomized Controlled Trial of "Once-Only SigmoidoscopyーーSCORE.J Natl
Cancer Inst. 2002:94(23):1763-72. doi: 10.1093/jnc794.23.1763. PMID 12464648
Segnan N, Armaroli P Bonelhi 1L, Risio M, Sciallero S, Zappa M, Andreoni B,
Arrigomi A, Bisanti L, Casella C, Crosta C, Faleini F, Ferrero E, Gnacomn 為,
Giuliami O, Santarelh A, Visioli CB, Zanetti R, Atkin WS, Senore Ci SCORE
Working Group. Once-Only Sigmoidoscopy in Colorecta1 Cancer Screen1mg:
63